CLINICAL_TRIALS
trial_result
· 2026-06-30
Clinical Trial Results: Study of PlasmaCap IG in Adults and Children With PIDD [Phase 3]
Summary
Phase 3 trial results for PlasmaCap IG in adults and children with primary immune deficiency diseases (PIDD) have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Evolve Biologics | Conditions: Primary Immune Deficiency Diseases (PIDD) | Phase 3 | Status: COMPLETED | Results posted: 2026-06-30